ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Anifrolumab Shows Benefit in Patients with Systemic Lupus Erythematosus americanpharmaceuticalreview
June 04, 2021A new post-hoc analysis of pooled data from the TULIP Phase III clinical trials being presented at the annual European Congress of Rheumatology (EULAR 2021) showed anifrolumab was consistently associated with improvements in both skin rash and ...
Pharma Sources Insight January 2025
